These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells. Li H; Xu L; Li C; Zhao L; Ma Y; Zheng H; Li Z; Zhang Y; Wang R; Liu Y; Qu X Mol Cancer; 2014 Jun; 13():136. PubMed ID: 24885194 [TBL] [Abstract][Full Text] [Related]
11. CD2-associated protein (CD2AP) enhances casitas B lineage lymphoma-3/c (Cbl-3/c)-mediated Ret isoform-specific ubiquitination and degradation via its amino-terminal Src homology 3 domains. Calco GN; Stephens OR; Donahue LM; Tsui CC; Pierchala BA J Biol Chem; 2014 Mar; 289(11):7307-19. PubMed ID: 24425877 [TBL] [Abstract][Full Text] [Related]
13. The protein content of an adaptor protein, STAP-2 is controlled by E3 ubiquitin ligase Cbl. Sekine Y; Yamamoto C; Ikeda O; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T Biochem Biophys Res Commun; 2009 Jun; 384(2):187-92. PubMed ID: 19401194 [TBL] [Abstract][Full Text] [Related]
14. miR-27b-3p Attenuates Muscle Atrophy by Targeting Cbl-b in Skeletal Muscles. Yang X; Li Z; Wang Z; Yu J; Ma M; Nie Q Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204692 [TBL] [Abstract][Full Text] [Related]
15. [Development of ubiquitin ligase inhibitor as a drug against unloading-mediated muscle atrophy]. Nikawa T Seikagaku; 2009 Jul; 81(7):614-8. PubMed ID: 19697867 [No Abstract] [Full Text] [Related]
16. E3 Ubiquitin Ligase Cbl-b Prevents Tumor Metastasis by Maintaining the Epithelial Phenotype in Multiple Drug-Resistant Gastric and Breast Cancer Cells. Xu L; Zhang Y; Qu X; Che X; Guo T; Cai Y; Li A; Li D; Li C; Wen T; Fan Y; Hou K; Ma Y; Hu X; Liu Y Neoplasia; 2017 Apr; 19(4):374-382. PubMed ID: 28334634 [TBL] [Abstract][Full Text] [Related]
17. The E3 ubiquitin ligase Cbl-b inhibits tumor growth in multidrug-resistant gastric and breast cancer cells. CHe X; Zhang Y; Qu X; Guo T; Ma Y; Li C; Fan Y; Hou K; Cai Y; Yu R; Zhou H; He X; Wu H; Liu Y; Xu L Neoplasma; 2017; 64(6):887-892. PubMed ID: 28895413 [TBL] [Abstract][Full Text] [Related]